Monopar Therapeutics (MNPR) Change in Accrued Expenses (2017 - 2026)
Monopar Therapeutics (MNPR) posted Change in Accrued Expenses of $738,682 for Q4 2025, down 34.9% from $1.14 million a year earlier but up 108.0% from the prior quarter.
Powered by 
Analysis
Monopar Therapeutics (MNPR) Change in Accrued Expenses (2017 - 2026) Analysis & Trends
For FY2025, Monopar Therapeutics' Change in Accrued Expenses came in at $388,218, down 23.4% from FY2024.
- Annual Change in Accrued Expenses shows a five-year compound annual growth rate of -2.8% (FY2020 to FY2025).
- In prior years, Monopar Therapeutics' Change in Accrued Expenses was $506,791 in FY2024, -$1.33 million in FY2023, $1.48 million in FY2022 (+265.9%) and $403,967 in FY2021 (-9.7%).
- Quarterly Change in Accrued Expenses has run from a low of -$770,968 in Q1 2025 to a high of $1.2 million in Q4 2022 over five years.
- According to Business Quant data, Change in Accrued Expenses for the three prior quarters was $355,101 (Q3 2025), $65,403 (Q2 2025) and -$770,968 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accrued Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 983.00 Mn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | -87.00 Mn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 756.00 Mn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | - |
| 10 | Monopar Therapeutics | 630.69 Mn | 335.88 Mn | - | 1.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.56 Mn |
| Mar 31, 2026 | -287,138.00 |
| Dec 31, 2025 | 738,682.00 |
| Sep 30, 2025 | 355,101.00 |
| Jun 30, 2025 | 65,403.00 |
| Mar 31, 2025 | -770,968.00 |
| Dec 31, 2024 | 1.14 Mn |
| Sep 30, 2024 | 28,692.00 |
| Jun 30, 2024 | -345,750.00 |
| Mar 31, 2024 | -311,239.00 |
| Dec 31, 2023 | -212,999.00 |
| Sep 30, 2023 | -496,889.00 |
| Jun 30, 2023 | -371,724.00 |
| Mar 31, 2023 | -251,924.00 |
| Dec 31, 2022 | 1.20 Mn |
| Sep 30, 2022 | -277,524.00 |
| Jun 30, 2022 | 1.09 Mn |
| Mar 31, 2022 | -532,321.00 |
| Dec 31, 2021 | 340,611.00 |
| Sep 30, 2021 | 136,298.00 |
API Access
Monopar Therapeutics Change in Accrued Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=MNPR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "MNPR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=MNPR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();